Abstract 4367292: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control
Year: 2025
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Circulation
Authors: Zin Win, Abbas Hussain, Ramaditya Srinivasmurthy, Riccesha Hattin, Daniel Jones, Rishi Nanda, Jason Ta, Timothy Chu, Tin Tun, Hazem Aboaid, Kevin Nguyen, Yin Myat, Matthew Chu, Khadija Mohib, Aziel Macias, Khaing Khaing Htwe, Kyaw Thein
Institutions: University of California, Riverside, University of Nevada, Las Vegas, Touro University Nevada, University of South Florida, HCA Healthcare, Western University of Health Sciences, University of New Mexico, Interfaith Medical Center, Riverside Community Hospital, University of Nevada, Reno, University of California, Los Angeles, Comprehensive Cancer Centers of Nevada
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415793726
FWCI:
Cites:
Cited by:
Related to: